SANOFICONRPharmaceuticals
Sanofi Consumer Healthcare Inc — PE Ratio & Valuation Analysis
₹4298.20
-3.13%
Current P/E49.57xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E62.7x20.9% below avg
⚠️
56.0% Premium to Industry
SANOFICONR P/E 49.57x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹78.59 | ₹4927 | 62.7x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Sanofi Consumer Healthcare Inc Valuation
Sanofi Consumer Healthcare Inc (SANOFICONR) currently trades at 49.57x earnings. The Pharmaceuticals sector average PE is 31.77x. SANOFICONR commands a premium, reflecting high growth expectations. Historically, SANOFICONR has traded at an average PE of 62.7x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
83.81%
Dividend Yield
1.19%
More on Sanofi Consumer Healthcare Inc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.